Completed NA INTERVENTIONAL NCT00004739
The Metabolic Effects of Protease Inhibitors in HIV Infected Children
Sponsor: Elizabeth Glaser Pediatric AIDS Foundation
Conditions
HIV Infections
Interventions
Antiretroviral therapy
Updated 5 times since 2017 Last updated: Jun 23, 2005
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT00004739, this NA trial focuses on HIV Infections and remains completed. Sponsored by Elizabeth Glaser Pediatric AIDS Foundation, it has been updated 5 times since 2026, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
-
Jan 2017 — Jun 2018 [monthly]
Completed NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Elizabeth Glaser Pediatric AIDS Foundation
- National Center for Research Resources (NCRR)
Data source: National Center for Research Resources (NCRR)
For direct contact, visit the study record on ClinicalTrials.gov .